The TUSCAVIR.NET consortium aims to set up a certified, interdisciplinary consortium doing research and providing qualified services for the development of novel antiviral therapies. The consortium is based on a well well-consolidated multidisciplinary partnership among University of Siena, Azienda Ospedaliera Senese, Azienda Ospedaliera Pisana, and University of Florence into a new, full- fledged operating model integrating drug discovery and development capabilities into a modular package in the framework of a certified system.
The final goal is to provide the Regional Healthcare System with a qualified, specialized instrument promoting the research and development process in the critical area of antiviral therapy, through optimization of existing expertise, infrastructures, and economical resources.
TUSCAVIR.NET aims to establish a framework where the multiple steps in the preclinical antiviral drug development process are tightly connected and integrated, providing a significant advancement with respect to the typically sparse availability of such building blocks.
This entire project focuses on:
• Setting up a multicenter organization running the whole process from discovery to development of novel antiviral drugs entirely located in Tuscany, to provide the Healthcare system with a new and effective tool.
• Optimizing existing expertise and economical resources into a new competitive and organizational model able to provide qualified services to both public and private third parties, attract investments and offer business opportunities.